Clinical Trial

Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

Study acronym: METRO
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Adult patients with a diagnosis of idiopathic retroperitoneal fibrosis Prospective multicentric cohort study Intervention : administration of prednisone during 9 to 21 months at 1mg/kg/day at inclusion.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-06-17; most recent amendment 2025-05-21.
Status change: Active, Not Recruiting → Recruiting 2022-12-07
Status change: Not Yet Recruiting → Active, Not Recruiting 2022-11-21
Trial Details
NCT Number NCT05428826
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Idiopathic Retroperitoneal Fibrosis
Enrollment 41 participants
Start Date 2022-11-25
Primary Completion 2026-11-25 (estimated)
Study Completion 2028-11-25 (estimated)
Updated on ClinicalTrials.gov 2025-05-25